Logo Image

Cassandra Aikman, MPH

Articles by Cassandra Aikman, MPH

AJMC

Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

ByDavid T. Liss, PhD,Manisha Cherupally, MS,Matthew J. O’Brien, MD, MSc,Raymond H. Kang, MA,Cassandra Aikman, MPH,Amisha Wallia, MD, MS,Andrew J. Cooper, MSc,Eleena Koep, MS,Emily D. Parker, PhD, MPH,Ronald T. Ackermann, MD, MPH

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.

Latest Updated Articles